Loading...

GILD GILEAD SCIENCES INC Capital Structure Changes 8-K Filing

GLD

GLD

GILEAD SCIENCES INC

(GILD)

2026 8-K

New Debt Issuance

Financial Results Announcement

Annual Meeting Results

Acquisition Completed

Merger Announcement

Financial Results Announced

Management Change

Earnings Report

Patent Settlement Announced

Management Change

Financial Statements

Board Amendments

Financial Statements

Management Change

Financial Results

Management Change

Financial Results

Financial Results Announcement

Departure of Chief Medical ...

Amendment to Restated Certi...

Financial Results Announcement

Acquisition of CymaBay Ther...

Departure of Director

Merger Agreement

Financial Results Announcement

Appointment of Director

Financial Results Announcement

Indenture for Senior Notes ...

Unauthorized Presentation P...

Financial Results Announcement

Approval of Amendment and R...

Financial Results Announcement

External Links:

Gilead Sciences, Inc. announced on May 20, 2026, the issuance of $3 billion in Senior Notes due between 2028 and 2034, intending to use proceeds for general corporate purposes. The issuance occurred following an underwriting agreement dated May 14, 2026.

AI Assistant

GILEAD SCIENCES INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.